Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Castle Biosciences Inc
(NQ:
CSTL
)
19.90
-0.02 (-0.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Castle Biosciences Inc
< Previous
1
2
3
Next >
7 Analysts Have This to Say About Castle Biosciences
June 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 05, 2023
Via
Benzinga
Dow Drops Triple Digits; S&P 500, Nasdaq Extend Highs
June 05, 2023
Via
Talk Markets
Stocks That Hit 52-Week Lows On Monday
June 05, 2023
Monday's session saw 41 companies set new 52-week lows.
Via
Benzinga
Why Shares of Castle Biosciences Slumped This Week
June 02, 2023
Investors were unimpressed by the company's study regarding its IDgenetix test.
Via
The Motley Fool
Looking Into Castle Biosciences's Return On Capital Employed
May 11, 2023
Via
Benzinga
Analyst Expectations for Castle Biosciences's Future
May 04, 2023
Via
Benzinga
Looking Into Castle Biosciences's Return On Capital Employed
November 16, 2022
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding.
Via
Benzinga
Nasdaq Rises 70 Points; ISM Services PMI Drops In May
June 05, 2023
U.S. stocks traded mixed midway through trading, with Nasdaq Composite gaining around 70 points on Monday. The Dow traded down 0.21% to 33,691.13 while the NASDAQ rose 0.54% to 13,312.65. The S&P 500,...
Via
Benzinga
Castle Biosciences: Q2 Earnings Insights
August 08, 2022
Castle Biosciences (NASDAQ:CSTL) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 28, 2022
February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...
Via
Benzinga
EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday
June 05, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Mixed; SAIC Posts Upbeat Results
June 05, 2023
U.S. stocks traded mixed this morning, with Dow Jones dropping around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.06% to 33,740.98 while the NASDAQ rose 0.08% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 01, 2023
Via
Benzinga
Why Victoria's Secret Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 01, 2023
Gainers Reunion Neuroscience Inc. (NASDAQ: REUN) gained 95% to $1.33 after the company announced a $13.1 million take-private transaction with MPM BioImpact.
Via
Benzinga
7 Value Stocks to Buy for Long-Term Growth
March 26, 2023
If you have the patience to ride out some choppy weather, these value stocks to buy may offer significant upside later.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 08, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
This Analyst With 90% Accuracy Rate Raises PT On Chesapeake Energy; Here Are 5 Stock Picks For Last Week From Benzinga's Most Accurate Analysts
November 07, 2022
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...
Via
Benzinga
This Analyst With 82% Accuracy Rate Boosts PT On Booking Holdings; Here Are 5 Stock Picks For Thursday From Benzinga's Most Accurate Analysts
November 04, 2022
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes...
Via
Benzinga
Castle Biosciences's Return On Capital Employed Overview
September 01, 2022
According to data from Benzinga Pro, during Q2, Castle Biosciences's (NASDAQ:CSTL) reported sales totaled $34.84 million. Despite a 93.31% increase in earnings, the company posted a loss of $1.65...
Via
Benzinga
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
May 11, 2022
Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF.
Via
InvestorPlace
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
June 24, 2022
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...
Via
Benzinga
Castle Biosciences Adds Mental Health Testing Solutions Via AltheaDx Acquisition
April 05, 2022
Castle Biosciences Inc (NASDAQ: CSTL) has agreed to acquire AltheaDx Inc, a commercial-stage molecular diagnostics company,
Via
Benzinga
51 Biggest Movers From Yesterday
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
Castle Biosciences: Q4 Earnings Insights
February 28, 2022
Castle Biosciences (NASDAQ:CSTL) reported its Q4 earnings results on Monday, February 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Castle Biosciences's Return On Capital Employed Overview
September 16, 2021
Castle Biosciences (NASDAQ:CSTL) brought in sales totaling $22.76 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 105.65%, resulting in a...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Upgrades According to Wolfe Research, the prior rating for CVR Energy Inc (NYSE:
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.